VISION FOR ALL

At EyeYon Medical, we are inventing a clearer future

EyeYon Medical develops solutions to heal corneas. We are positioned at the forefront of ophthalmology. Our innovative technologies are targeted to preserve the vision of millions of patients worldwide.

Read More

EndoArt®: The future of
corneal transplants

EndoArt® is the first synthetic implant to treat corneal edema and save vision. We are breaking the barriers for corneas, the most common organ transplant worldwide.

EndoArt

Hyper-CL™: Design to deliver

Hyper-CL™ therapeutic contact lens provides a novel solution for the treatment of corneal conditions, increasing bioavailability of any topical drop.

Read More

Prof. Gerd U. Auffarth

Heidelberg MC, Germany

Prof. Merab Dvali

Tbilisi State Medical University, Georgia

Dr. Naftali Modi

Rambam MC, Haifa, Israel

Dr Sunita Chaurasia

LV Prasad Eye Institute Hyderabad, India

Prof. Irit Barequet, MD

Sheba Medical Center, Israel

Prof. Francis Mah, MD

San Diego, CA, USA

Prof. Lional Raj, MD

Tirunelveli, India

Dr Boris Knyazer MD, Soroka

Soroka Medical Center

Dr. Moshe Mendelson,

Silicon Valley Eye Physicians 

Dr. Navneet Toshniwal,

Dr. Nitin Toshniwal’s Navneet Hospital & Vaccination Centre

The EndoArt could provide a paradigm shift in the treatment of patients with endothelial failure while eliminating the need for human donor tissue.

I’m grateful…to take first steps towards eliminating the global shortage of corneal tissue

The EndoArt® is a critical step forward as the ideal solution for the problem of corneal failure as an “on the shelf” solution for almost every ophthalmic surgeon, not only corneal specialist.

The introduction of EndoArt, which serves as an artificial layer reducing the fluid transfer from the aqueous to the corneal stroma, is a huge step forward.

The proportion of patients achieving a significant improvement in CCT and BCVA was greater in the therapeutic Hyper-CL group. In addition, the therapeutic Hyper-CL group had a greater improvement in mean BCVA and mean CCT.

I was able to try the Hyper-CL™ in a patient with a corneal melt, significant corneal edema, and Serratia infectious keratitis. The result was dramatic. The patient had resolution within a week with complete resolution of the patient’s AC inflammation/hypopyon.  The epithelium was completely healed, and the infiltrate was almost completely resolved.  Usually, these are long courses that take an average of 2 weeks to resolve.

The concept of using a novel drug repository contact lens is effective in prolonging corneal antimicrobial availability and drug contact time over the lesion and has demonstrated faster corneal healing, which may affect the overall outcomes in bacterial keratitis. Using a drug depo contact lens, may reduce the regimen of antibiotics, decrease treatment burden on the medical staff, improve patient tolerance, and reduce toxicities.

Upon Hyper CL™ insertion, as well as hyperosmotic saline application, patients were extremely surprised to find a significant sight improvement, emphasizing the high level of excitement and significance those patients were experiencing.

Excellent results for our first patient. Patient and I satisfied with outcome. His Visual acuity improved from 20/200- to 20/60+.

I used lens for bullous keratopathy with excellent result. Corneal condition improves and then visual acuity too. I am excited to use more.

Latest News

November 2023

Our CEO & Co-Founder Nahum Ferera on the Odelle Technology Podcastwas our most succesful year so far!

Nahum Ferera,  our CEO & Co-Founder of EyeYon Medical, describes his career and the origins of EyeYon Medical in the Odelle Technology podcast with Steven Haken.  He explains how the company has developed a contact lens that acts as a drug depot, and our flagship technology, EndoArt®, which is a definitive solution for corneal edema. Nahum talks about the successes of the company, the breakthroughs and the upcoming exciting opportunities. Watch the podcast to find out more.

Read
3rd-6th November 2023

4AAO 2023

We are looking forward to attending the American Academy of Ophthalmology event in San Francisco next week!

Read
October 2023

Combined Use of Therapeutic Hyper-CL Soft Contact Lens and Insulin Eye Drops for the Treatment of Recalcitrant Neurotrophic Keratopathy

Read the full publication

Read
News

Check out the latest news

Events

Check out our recent events!

Publications

Read the latest publications